The “leaf extracts of cannabis sativa” has “potential for the control of both hospital- and community-acquired MRSA”, according to a new study being published by the Journal of Integrative Medicine, and epublished ahead of print by the U.S. National Institute of Health.
“This study examined the antimicrobial activity of Cannabis sativa, Thuja orientalis and Psidium guajava against methicillin-resistant Staphylococcus aureus (MRSA)”, states the study’s abstract.
For the study, “In vitro antimicrobial activities of the ethanolic extracts of C. sativa, T. orientalis and P. guajava were tested against MRSA”, and the “presence of bioactive molecules in these three leaves was evaluated using biochemical assays and high-performance thin-layer chromatography (HPTLC).”
Researchers state that “A profound synergism was observed when C. sativa was used in combination with T. orientalis (1:1) and when P. guajava was used in combination with T. orientalis (1:1)”. This synergism “was probably due to the combined inhibitory effect of phenolics present in the leaf extracts (i.e., quercetin and gallic acid) and catechin, as detected by HPTLC.”
The study concludes by stating that “The leaf extracts of C. sativa, T. orientalis and P. guajava had potential for the control of both hospital- and community-acquired MRSA. Moreover, the inhibitory effect was enhanced when extracts were used in combination.”
More information on this study can be found by clicking here.